| ICD10 Code - Description | LCD Code | NCD Code |
|---|
|
| A15 - Respiratory tuberculosis | | |
|
| A15.0 - Tuberculosis of lung | | |
|
| A17 - Tuberculosis of nervous system | | |
|
| A18 - Tuberculosis of other organs | | |
|
| A18.11 - Tuberculosis of kidney and ureter | | |
|
| A19 - Miliary tuberculosis | | |
|
| A19.0 - Acute miliary tuberculosis of a single specified site | | |
|
| A19.1 - Acute miliary tuberculosis of multiple sites | | |
|
| A19.2 - Acute miliary tuberculosis, unspecified | | |
|
| A19.9 - Miliary tuberculosis, unspecified | | |
|
| A31 - Infection due to other mycobacteria | | |
|
| B02 - Zoster [herpes zoster] | | |
|
| B02.23 - Postherpetic polyneuropathy | | |
|
| B15 - Acute hepatitis A | | |
|
| B16 - Acute hepatitis B | | |
|
| B16.9 - Acute hepatitis B without delta-agent and without hepatic coma | | |
|
| B17 - Other acute viral hepatitis | | |
|
| B17.0 - Acute delta-(super) infection of hepatitis B carrier | | |
|
| B17.8 - Other specified acute viral hepatitis | | |
|
| B18 - Chronic viral hepatitis | | |
|
| B18.0 - Chronic viral hepatitis B with delta-agent | | |
|
| B18.1 - Chronic viral hepatitis B without delta-agent | | |
|
| B18.2 - Chronic viral hepatitis C | | |
|
| B18.8 - Other chronic viral hepatitis | | |
|
| B18.9 - Chronic viral hepatitis, unspecified | | |
|
| B19 - Unspecified viral hepatitis | | |
|
| B19.0 - Unspecified viral hepatitis with hepatic coma | | |
|
| B19.1 - Unspecified viral hepatitis B | | |
|
| B19.10 - Unspecified viral hepatitis B without hepatic coma | | |
|
| B19.11 - Unspecified viral hepatitis B with hepatic coma | | |
|
| B19.9 - Unspecified viral hepatitis without hepatic coma | | |
|
| B90 - Sequelae of tuberculosis | | |
|
| C22 - Malignant neoplasm of liver and intrahepatic bile ducts | | |
|
| C22.0 - Liver cell carcinoma | | |
|
| C22.1 - Intrahepatic bile duct carcinoma | | |
|
| C22.8 - Malignant neoplasm of liver, primary, unspecified as to type | | |
|
| C22.9 - Malignant neoplasm of liver, not specified as primary or secondary | | |
|
| C24 - Malignant neoplasm of other and unspecified parts of biliary tract | | |
|
| C24.0 - Malignant neoplasm of extrahepatic bile duct | | |
|
| C77 - Secondary and unspecified malignant neoplasm of lymph nodes | | |
|
| C77.8 - Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions | | |
|
| C77.9 - Secondary and unspecified malignant neoplasm of lymph node, unspecified | | |
|
| C82 - Follicular lymphoma | | |
|
| C82.89 - Other types of follicular lymphoma, extranodal and solid organ sites | | |
|
| C82.90 - Follicular lymphoma, unspecified, unspecified site | | |
|
| C82.99 - Follicular lymphoma, unspecified, extranodal and solid organ sites | | |
|
| C83 - Non-follicular lymphoma | | |
|
| C83.1 - Mantle cell lymphoma | | |
|
| C83.10 - Mantle cell lymphoma, unspecified site | | |
|
| C83.11 - Mantle cell lymphoma, lymph nodes of head, face, and neck | | |
|
| C83.12 - Mantle cell lymphoma, intrathoracic lymph nodes | | |
|
| C83.13 - Mantle cell lymphoma, intra-abdominal lymph nodes | | |
|
| C83.14 - Mantle cell lymphoma, lymph nodes of axilla and upper limb | | |
|
| C83.15 - Mantle cell lymphoma, lymph nodes of inguinal region and lower limb | | |
|
| C83.16 - Mantle cell lymphoma, intrapelvic lymph nodes | | |
|
| C83.17 - Mantle cell lymphoma, spleen | | |
|
| C83.18 - Mantle cell lymphoma, lymph nodes of multiple sites | | |
|
| C83.19 - Mantle cell lymphoma, extranodal and solid organ sites | | |
|
| C83.3 - Diffuse large B-cell lymphoma | | |
|
| C83.30 - Diffuse large B-cell lymphoma, unspecified site | | |
|
| C85 - Other specified and unspecified types of non-Hodgkin lymphoma | | |
|
| C85.8 - Other specified types of non-Hodgkin lymphoma | | |
|
| C85.80 - Other specified types of non-Hodgkin lymphoma, unspecified site | | |
|
| C85.86 - Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes | | |
|
| C85.89 - Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites | | |
|
| C85.9 - Non-Hodgkin lymphoma, unspecified | | |
|
| C85.90 - Non-Hodgkin lymphoma, unspecified, unspecified site | | |
|
| C85.91 - Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck | | |
|
| C85.92 - Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes | | |
|
| C85.93 - Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes | | |
|
| C88 - Malignant immunoproliferative diseases and certain other B-cell lymphomas | | |
|
| D13 - Benign neoplasm of other and ill-defined parts of digestive system | | |
|
| D13.4 - Benign neoplasm of liver | | |
|
| D13.5 - Benign neoplasm of extrahepatic bile ducts | | |
|
| D37.1 - Neoplasm of uncertain behavior of stomach | | |
|
| D37.9 - Neoplasm of uncertain behavior of digestive organ, unspecified | | |
|
| D63 - Anemia in chronic diseases classified elsewhere | | |
|
| D63.1 - Anemia in chronic kidney disease | | |
|
| D69 - Purpura and other hemorrhagic conditions | | |
|
| D69.3 - Immune thrombocytopenic purpura | | |
|
| D69.4 - Other primary thrombocytopenia | | |
|
| D69.6 - Thrombocytopenia, unspecified | | |
|
| D69.8 - Other specified hemorrhagic conditions | | |
|
| D89 - Other disorders involving the immune mechanism, not elsewhere classified | | |
|
| D89.1 - Cryoglobulinemia | | |
|
| E10.41 - Type 1 diabetes mellitus with diabetic mononeuropathy | | |
|
| E71.522 - Adrenomyeloneuropathy | | |
|
| F11 - Opioid related disorders | | |
|
| F11.1 - Opioid abuse | | |
|
| F11.10 - Opioid abuse, uncomplicated | | |
|
| F11.12 - Opioid abuse with intoxication | | |
|
| F11.2 - Opioid dependence | | |
|
| F11.20 - Opioid dependence, uncomplicated | | |
|
| F11.21 - Opioid dependence, in remission | | |
|
| F11.9 - Opioid use, unspecified | | |
|
| F11.90 - Opioid use, unspecified, uncomplicated | | |
|
| F11.92 - Opioid use, unspecified with intoxication | | |
|
| F12 - Cannabis related disorders | | |
|
| F12.1 - Cannabis abuse | | |
|
| F13 - Sedative, hypnotic, or anxiolytic related disorders | | |
|
| F13.1 - Sedative, hypnotic or anxiolytic-related abuse | | |
|
| F13.10 - Sedative, hypnotic or anxiolytic abuse, uncomplicated | | |
|
| F14 - Cocaine related disorders | | |
|
| F14.1 - Cocaine abuse | | |
|
| F15 - Other stimulant related disorders | | |
|
| F15.1 - Other stimulant abuse | | |
|
| F15.10 - Other stimulant abuse, uncomplicated | | |
|
| F16 - Hallucinogen related disorders | | |
|
| F16.1 - Hallucinogen abuse | | |
|
| F17.2 - Nicotine dependence | | |
|
| F18 - Inhalant related disorders | | |
|
| F18.1 - Inhalant abuse | | |
|
| F18.10 - Inhalant abuse, uncomplicated | | |
|
| F19 - Other psychoactive substance related disorders | | |
|
| F19.1 - Other psychoactive substance abuse | | |
|
| F19.10 - Other psychoactive substance abuse, uncomplicated | | |
|
| F19.11 - Other psychoactive substance abuse, in remission | | |
|
| F19.12 - Other psychoactive substance abuse with intoxication | | |
|
| F19.2 - Other psychoactive substance dependence | | |
|
| F19.20 - Other psychoactive substance dependence, uncomplicated | | |
|
| F19.9 - Other psychoactive substance use, unspecified | | |
|
| F55 - Abuse of non-psychoactive substances | | |
|
| G58 - Other mononeuropathies | | |
|
| G58.9 - Mononeuropathy, unspecified | | |
|
| G60 - Hereditary and idiopathic neuropathy | | |
|
| G60.0 - Hereditary motor and sensory neuropathy | | |
|
| G60.3 - Idiopathic progressive neuropathy | | |
|
| G60.8 - Other hereditary and idiopathic neuropathies | | |
|
| G61 - Inflammatory polyneuropathy | | |
|
| G61.1 - Serum neuropathy | | |
|
| G62 - Other and unspecified polyneuropathies | | |
|
| G62.9 - Polyneuropathy, unspecified | | |
|
| G63 - Polyneuropathy in diseases classified elsewhere | | |
|
| G90.0 - Idiopathic peripheral autonomic neuropathy | | |
|
| G99 - Other disorders of nervous system in diseases classified elsewhere | | |
|
| G99.0 - Autonomic neuropathy in diseases classified elsewhere | | |
|
| I12 - Hypertensive chronic kidney disease | | |
|
| I12.0 - Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease | | |
|
| I13 - Hypertensive heart and chronic kidney disease | | |
|
| I77 - Other disorders of arteries and arterioles | | |
|
| I77.6 - Arteritis, unspecified | | |
|
| K65 - Peritonitis | | |
|
| K65.1 - Peritoneal abscess | | |
|
| K70 - Alcoholic liver disease | | |
|
| K70.0 - Alcoholic fatty liver | | |
|
| K70.1 - Alcoholic hepatitis | | |
|
| K70.10 - Alcoholic hepatitis without ascites | | |
|
| K70.11 - Alcoholic hepatitis with ascites | | |
|
| K70.9 - Alcoholic liver disease, unspecified | | |
|
| K71 - Toxic liver disease | | |
|
| K71.3 - Toxic liver disease with chronic persistent hepatitis | | |
|
| K71.9 - Toxic liver disease, unspecified | | |
|
| K72 - Hepatic failure, not elsewhere classified | | |
|
| K72.0 - Acute and subacute hepatic failure | | |
|
| K72.00 - Acute and subacute hepatic failure without coma | | |
|
| K72.01 - Acute and subacute hepatic failure with coma | | |
|
| K72.11 - Chronic hepatic failure with coma | | |
|
| K72.90 - Hepatic failure, unspecified without coma | | |
|
| K72.91 - Hepatic failure, unspecified with coma | | |
|
| K73 - Chronic hepatitis, not elsewhere classified | | |
|
| K73.9 - Chronic hepatitis, unspecified | | |
|
| K74 - Fibrosis and cirrhosis of liver | | |
|
| K74.0 - Hepatic fibrosis | | |
|
| K74.6 - Other and unspecified cirrhosis of liver | | |
|
| K74.60 - Unspecified cirrhosis of liver | | |
|
| K74.69 - Other cirrhosis of liver | | |
|
| K75 - Other inflammatory liver diseases | | |
|
| K75.0 - Abscess of liver | | |
|
| K75.4 - Autoimmune hepatitis | | |
|
| K75.81 - Nonalcoholic steatohepatitis (NASH) | | |
|
| K76 - Other diseases of liver | | |
|
| K76.0 - Fatty (change of) liver, not elsewhere classified | | |
|
| K76.1 - Chronic passive congestion of liver | | |
|
| K76.2 - Central hemorrhagic necrosis of liver | | |
|
| K76.3 - Infarction of liver | | |
|
| K76.8 - Other specified diseases of liver | | |
|
| K76.89 - Other specified diseases of liver | | |
|
| K76.9 - Liver disease, unspecified | | |
|
| K77 - Liver disorders in diseases classified elsewhere | | |
|
| L93 - Lupus erythematosus | | |
|
| L95 - Vasculitis limited to skin, not elsewhere classified | | |
|
| M05 - Rheumatoid arthritis with rheumatoid factor | | |
|
| M05.2 - Rheumatoid vasculitis with rheumatoid arthritis | | |
|
| M05.5 - Rheumatoid polyneuropathy with rheumatoid arthritis | | |
|
| M13.0 - Polyarthritis, unspecified | | |
|
| M25.48 - Effusion, other site | | |
|
| M25.5 - Pain in joint | | |
|
| M30 - Polyarteritis nodosa and related conditions | | |
|
| M30.0 - Polyarteritis nodosa | | |
|
| M30.1 - Polyarteritis with lung involvement [Churg-Strauss] | | |
|
| M30.8 - Other conditions related to polyarteritis nodosa | | |
|
| M31 - Other necrotizing vasculopathies | | |
|
| M31.1 - Thrombotic microangiopathy | | |
|
| M31.3 - Wegener's granulomatosis | | |
|
| M31.30 - Wegener's granulomatosis without renal involvement | | |
|
| M31.31 - Wegener's granulomatosis with renal involvement | | |
|
| M31.4 - Aortic arch syndrome [Takayasu] | | |
|
| M32 - Systemic lupus erythematosus (SLE) | | |
|
| M32.0 - Drug-induced systemic lupus erythematosus | | |
|
| N00 - Acute nephritic syndrome | | |
|
| N00.3 - Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis | | |
|
| N00.8 - Acute nephritic syndrome with other morphologic changes | | |
|
| N00.9 - Acute nephritic syndrome with unspecified morphologic changes | | |
|
| N02 - Recurrent and persistent hematuria | | |
|
| N02.8 - Recurrent and persistent hematuria with other morphologic changes | | |
|
| N03 - Chronic nephritic syndrome | | |
|
| N03.0 - Chronic nephritic syndrome with minor glomerular abnormality | | |
|
| N03.2 - Chronic nephritic syndrome with diffuse membranous glomerulonephritis | | |
|
| N03.5 - Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis | | |
|
| N03.7 - Chronic nephritic syndrome with diffuse crescentic glomerulonephritis | | |
|
| N03.9 - Chronic nephritic syndrome with unspecified morphologic changes | | |
|
| N04 - Nephrotic syndrome | | |
|
| N04.8 - Nephrotic syndrome with other morphologic changes | | |
|
| N04.9 - Nephrotic syndrome with unspecified morphologic changes | | |
|
| N05 - Unspecified nephritic syndrome | | |
|
| N05.2 - Unspecified nephritic syndrome with diffuse membranous glomerulonephritis | | |
|
| N05.5 - Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis | | |
|
| N06 - Isolated proteinuria with specified morphological lesion | | |
|
| N08 - Glomerular disorders in diseases classified elsewhere | | |
|
| N13 - Obstructive and reflux uropathy | | |
|
| N18 - Chronic kidney disease (CKD) | | |
|
| N18.6 - End stage renal disease | | |
|
| N18.9 - Chronic kidney disease, unspecified | | |
|
| N23 - Unspecified renal colic | | |
|
| N26 - Unspecified contracted kidney | | |
|
| N26.9 - Renal sclerosis, unspecified | | |
|
| N98.3 - Complications of attempted introduction of embryo in embryo transfer | | |
|
| O09 - Supervision of high risk pregnancy | | |
|
| O09.3 - Supervision of pregnancy with insufficient antenatal care | | |
|
| O12 - Gestational [pregnancy-induced] edema and proteinuria without hypertension | | |
|
| O23.9 - Unspecified genitourinary tract infection in pregnancy | | |
|
| O23.90 - Unspecified genitourinary tract infection in pregnancy, unspecified trimester | | |
|
| O23.91 - Unspecified genitourinary tract infection in pregnancy, first trimester | | |
|
| O23.92 - Unspecified genitourinary tract infection in pregnancy, second trimester | | |
|
| O23.93 - Unspecified genitourinary tract infection in pregnancy, third trimester | | |
|
| O26 - Maternal care for other conditions predominantly related to pregnancy | | |
|
| O28 - Abnormal findings on antenatal screening of mother | | |
|
| O28.9 - Unspecified abnormal findings on antenatal screening of mother | | |
|
| O35 - Maternal care for known or suspected fetal abnormality and damage | | |
|
| O35.0 - Maternal care for (suspected) central nervous system malformation in fetus | | |
|
| O36.01 - Maternal care for anti-D [Rh] antibodies | | |
|
| O86.2 - Urinary tract infection following delivery | | |
|
| O99.01 - Anemia complicating pregnancy | | |
|
| O99.280 - Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester | | |
|
| O99.810 - Abnormal glucose complicating pregnancy | | |
|
| O99.814 - Abnormal glucose complicating childbirth | | |
|
| O99.830 - Other infection carrier state complicating pregnancy | | |
|
| P58 - Neonatal jaundice due to other excessive hemolysis | | |
|
| P59 - Neonatal jaundice from other and unspecified causes | | |
|
| P59.0 - Neonatal jaundice associated with preterm delivery | | |
|
| P59.9 - Neonatal jaundice, unspecified | | |
|
| R05 - Cough | | |
|
| R16 - Hepatomegaly and splenomegaly, not elsewhere classified | | |
|
| R17 - Unspecified jaundice | | |
|
| R18 - Ascites | | |
|
| R18.8 - Other ascites | | |
|
| R19 - Other symptoms and signs involving the digestive system and abdomen | | |
|
| R19.0 - Intra-abdominal and pelvic swelling, mass and lump | | |
|
| R43.0 - Anosmia | | |
|
| R74 - Abnormal serum enzyme levels | | |
|
| R74.0 - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH] | | |
|
| R74.01 - Elevation of levels of liver transaminase levels | | |
|
| R77 - Other abnormalities of plasma proteins | | |
|
| R78 - Findings of drugs and other substances, not normally found in blood | | |
|
| R78.1 - Finding of opiate drug in blood | | |
|
| R78.2 - Finding of cocaine in blood | | |
|
| R78.4 - Finding of other drugs of addictive potential in blood | | |
|
| R78.5 - Finding of other psychotropic drug in blood | | |
|
| R80 - Proteinuria | | |
|
| R94 - Abnormal results of function studies | | |
|
| R94.4 - Abnormal results of kidney function studies | | |
|
| R94.5 - Abnormal results of liver function studies | | |
|
| T38 - Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified | | |
|
| T39 - Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics | | |
|
| T39.013 - Poisoning by aspirin, assault | | |
|
| T39.094S - Poisoning by salicylates, undetermined, sequela | | |
|
| T39.1 - Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives | | |
|
| T39.1X1 - Poisoning by 4-Aminophenol derivatives, accidental (unintentional) | | |
|
| T39.1X2 - Poisoning by 4-Aminophenol derivatives, intentional self-harm | | |
|
| T39.1X3 - Poisoning by 4-Aminophenol derivatives, assault | | |
|
| T39.1X4 - Poisoning by 4-Aminophenol derivatives, undetermined | | |
|
| T40 - Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] | | |
|
| T40.0X - Poisoning by, adverse effect of and underdosing of opium | | |
|
| T40.2X5 - Adverse effect of other opioids | | |
|
| T42.4X5A - Adverse effect of benzodiazepines, initial encounter | | |
|
| T86 - Complications of transplanted organs and tissue | | |
|
| T86.4 - Complications of liver transplant | | |
|
| T86.40 - Unspecified complication of liver transplant | | |
|
| T86.41 - Liver transplant rejection | | |
|
| T86.42 - Liver transplant failure | | |
|
| T86.43 - Liver transplant infection | | |
|
| T86.49 - Other complications of liver transplant | | |
|
| Z00 - Encounter for general examination without complaint, suspected or reported diagnosis | | |
|
| Z00.0 - Encounter for general adult medical examination | | |
|
| Z00.00 - Encounter for general adult medical examination without abnormal findings | | |
|
| Z00.01 - Encounter for general adult medical examination with abnormal findings | | |
|
| Z00.8 - Encounter for other general examination | | |
|
| Z01.41 - Encounter for routine gynecological examination | | |
|
| Z01.411 - Encounter for gynecological examination (general) (routine) with abnormal findings | | |
|
| Z01.83 - Encounter for blood typing | | |
|
| Z01.84 - Encounter for antibody response examination | | |
|
| Z02 - Encounter for administrative examination | | |
|
| Z04 - Encounter for examination and observation for other reasons | | |
|
| Z11.1 - Encounter for screening for respiratory tuberculosis | | |
|
| Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission | | |
|
| Z11.4 - Encounter for screening for human immunodeficiency virus [HIV] | | |
|
| Z11.5 - Encounter for screening for other viral diseases | | |
|
| Z11.51 - Encounter for screening for human papillomavirus (HPV) | | |
|
| Z11.59 - Encounter for screening for other viral diseases | | |
|
| Z12.10 - Encounter for screening for malignant neoplasm of intestinal tract, unspecified | | |
|
| Z13.1 - Encounter for screening for diabetes mellitus | | |
|
| Z13.220 - Encounter for screening for lipoid disorders | | |
|
| Z13.40 - Encounter for screening for unspecified developmental delays | | |
|
| Z13.41 - Encounter for autism screening | | |
|
| Z13.42 - Encounter for screening for global developmental delays (milestones) | | |
|
| Z13.6 - Encounter for screening for cardiovascular disorders | | |
|
| Z16 - Resistance to antimicrobial drugs | | |
|
| Z20 - Contact with and (suspected) exposure to communicable diseases | | |
|
| Z20.5 - Contact with and (suspected) exposure to viral hepatitis | | |
|
| Z22.50 - | | |
|
| Z22.59 - | | |
|
| Z30.014 - Encounter for initial prescription of intrauterine contraceptive device | | |
|
| Z30.8 - Encounter for other contraceptive management | | |
|
| Z32.0 - Encounter for pregnancy test | | |
|
| Z33 - Pregnant state | | |
|
| Z34 - Encounter for supervision of normal pregnancy | | |
|
| Z34.0 - Encounter for supervision of normal first pregnancy | | |
|
| Z34.00 - Encounter for supervision of normal first pregnancy, unspecified trimester | | |
|
| Z34.8 - Encounter for supervision of other normal pregnancy | | |
|
| Z34.9 - Encounter for supervision of normal pregnancy, unspecified | | |
|
| Z34.90 - Encounter for supervision of normal pregnancy, unspecified, unspecified trimester | | |
|
| Z36 - Encounter for antenatal screening of mother | | |
|
| Z36.0 - Encounter for antenatal screening for chromosomal anomalies | | |
|
| Z36.4 - Encounter for antenatal screening for fetal growth retardation | | |
|
| Z36.8 - Encounter for other antenatal screening | | |
|
| Z48.23 - Encounter for aftercare following liver transplant | | |
|
| Z51.81 - Encounter for therapeutic drug level monitoring | | |
|
| Z67 - Blood type | | |
|
| Z68 - Body mass index [BMI] | | |
|
| Z71.5 - Drug abuse counseling and surveillance | | |
|
| Z71.51 - Drug abuse counseling and surveillance of drug abuser | | |
|
| Z71.52 - Counseling for family member of drug abuser | | |
|
| Z77 - Other contact with and (suspected) exposures hazardous to health | | |
|
| Z77.120 - Contact with and (suspected) exposure to mold (toxic) | | |
|
| Z79 - Long term (current) drug therapy | | |
|
| Z79.1 - Long term (current) use of non-steroidal anti-inflammatories (NSAID) | | |
|
| Z79.52 - Long term (current) use of systemic steroids | | |
|
| Z79.89 - Other long term (current) drug therapy | | |
|
| Z79.890 - Hormone replacement therapy | | |
|
| Z79.891 - Long term (current) use of opiate analgesic | | |
|
| Z79.899 - Other long term (current) drug therapy | | |
|
| Z84 - Family history of other conditions | | |
|
| Z85 - Personal history of malignant neoplasm | | |
|
| Z85.05 - Personal history of malignant neoplasm of liver | | |
|
| Z85.09 - Personal history of malignant neoplasm of other digestive organs | | |
|
| Z85.72 - Personal history of non-Hodgkin lymphomas | | |
|
| Z86.11 - Personal history of tuberculosis | | |
|
| Z87.798 - Personal history of other (corrected) congenital malformations | | |
|
| Z94.4 - Liver transplant status | | |
|